https://www.selleckchem.com/pr....oducts/danicamtiv-my
54 mg/dl, 95 % CI -19.58 to 2.49, P = 0.129) level. Chromium supplementation may significantly improve lipid profile in patients with T2DM by decreasing TG and TC and increasing HDL. However, based on our analysis, chromium failed to affect LDL. It should be noted that the lipid-lowering properties of chromium supplementation were small and may not reach clinical importance. Chromium supplementation may significantly improve lipid profile in patients with T2DM by decreasing TG and TC and increasing HDL. However, based on our
Like
Comment
Share
